SuperworthTonix Pharmaceuticals shares outstanding TNXP
Diluted shares outstanding, averaged over each quarter, from 2011.
- Latest quarter, to Jun 30, 2026
- 16.6M
- On a year earlier
- +127.0%
- more shares
Tonix Pharmaceuticals had 16.6M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 127.0% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 11.8M | +118793% |
| FY2023 | 9.9K | +219% |
| FY2022 | 3.1K | −30% |
| FY2021 | 4.4K | +178% |
| FY2020 | 1.6K | +4088% |
| FY2019 | 38 | +2101% |
| FY2018 | 2 | +128% |
| FY2017 | 1 | +117% |
| FY2016 | 0 | +91% |
| FY2015 | 0 | +75% |
| FY2014 | 0 | +115% |
| FY2013 | 0 | +184% |
| FY2012 | 0 | +33% |
| FY2011 | 0 | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 16.6M | +127% | |
| Q1 FY26 | 13.7M | +131% | |
| Q4 FY25 | 11.8M | n/a | |
| Q3 FY25 | 8.9M | +1324% | |
| Q2 FY25 | 7.3M | +17767% | |
| Q1 FY25 | 5.9M | +21155% | |
| Q3 FY24 | 626.7K | +8553% | |
| Q2 FY24 | 41K | +612% | |
| Q1 FY24 | 27.9K | +769% | |
| Q4 FY23 | 9.9K | +219% | |
| Q3 FY23 | 7.2K | +239% | |
| Q2 FY23 | 5.8K | +414% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Tonix Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.